Eltrombopag for chronic immune thrombocytopenia

Lancet. 2011 Jun 4;377(9781):1919; author reply 1919-20. doi: 10.1016/S0140-6736(11)60809-X.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Asia / ethnology
  • Benzoates / administration & dosage*
  • Benzoates / pharmacokinetics
  • Chronic Disease
  • Humans
  • Hydrazines / administration & dosage*
  • Hydrazines / pharmacokinetics
  • Multicenter Studies as Topic
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / ethnology
  • Pyrazoles / administration & dosage*
  • Pyrazoles / pharmacokinetics
  • Randomized Controlled Trials as Topic
  • Receptors, Thrombopoietin / agonists*

Substances

  • Benzoates
  • Hydrazines
  • Pyrazoles
  • Receptors, Thrombopoietin
  • eltrombopag